To understand the molecular mechanisms underlying the induction of synergistic anti-ALCL effects, we focused on genes whose expression was up-regulated specifically by the combination of OR21 and alectinib, and identified SRPF5, GPR171, and CEL (Figure 4e). Here, GPR171 is linked to anaplastic large cell lymphoma.